News

Merck & Co. Inc. stock underperforms Wednesday when compared to competitors
Shares of Merck & Co. Inc. MRK slid 2.46% to $76.46 Wednesday, on what proved to be an all-around grim trading session for the stock market, with the S&P 500 Index SPX falling 2.24% to 5,275.70 and ...
Is Merck & Co., Inc. (MRK) the Best Pharma Stock to Buy for Long Term Growth?
We recently published a list of 10 Best Pharma Stocks to Buy for Long Term Growth. In this article, we are going to take a ...
Is Merck & Co Inc. (NYSE:MRK) the Most Undervalued Quality Stock to Buy Now?
We recently published a list of the 11 Most Undervalued Quality Stocks to Buy Now. In this article, we are going to take a ...
Cyprumed Enters License and Option Agreement with MSD for the Development of Oral Peptide Therapeutics
MSD obtains a Non-Exclusive License for Cyprumed’s delivery technology to develop oral peptide therapeuticsCyprumed will be eligible to receive ...